OKYO Pharma Limited - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
OKYO Nasdaq 2836 okyopharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for OKYO Pharma Limited

OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences - Sep 29th, 2026 5:00 am
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026 - Sep 9th, 2026 5:00 am
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference - Sep 8th, 2026 5:00 am
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer - Jul 28th, 2026 5:00 am
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026 - Jul 27th, 2026 5:00 am
OKYO Pharma Announces Purchase of Shares by Director - Jul 23rd, 2026 10:00 am
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer - Jul 23rd, 2026 5:00 am
OKYO Pharma Announces Purchase of Shares by Chairman - Jul 22nd, 2026 10:00 am
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director - Jul 22nd, 2026 8:00 am
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer - Jul 22nd, 2026 5:00 am
Sector Update: Healthcare Stocks Rise Late Afternoon - Jul 21st, 2026 1:40 pm
OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - Jul 21st, 2026 7:00 am